The drug company GSK has agreed to sell cervical cancer vaccine to GAVI at no profit. This marks a sea change in GSK’s approach to transparency. But GAVI wants to drive prices down even more.
Photo: Karel Prinsloo / GAVI
The rest of the content is only available for subscribers.
Log in or subscribe